None listed
Conditions
Interventions
Intervention1: Hair Forever SLS Free Shampoo: Take 5ml and apply on wet hair and scalp, massage gently and leave it for 2minutes, lather and rinse thoroughly with water. Use as per normal cleansing ro
Revitalizing oil: Take sufficient quantity and apply to the root of hairs &
scalp by parting the hairs, and massage gently for 4-5 minutes at bed time daily. Product to be applied Daily.
Intervention3: Hair Forever Growth Enhancer Gel: Take 5 to 10ml of Gel and massage gently
Sponsors
TVC Sky Shop Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1.Voluntary men suffering from androgenetic alopecia grade 2 vertex, 3 and 4. 2.Age: 18 to 55 years. 3.Not having done any cosmetic hair treatments i.e. coloring, bleaching, and henna, etc for last 1 month. 4.Has been fully informed verbally and in writing to comply with the study specifications. 5.Having signed a Consent Form and will be once informed orally and in writing of all information concerning the study procedures and study objectives. 6.Presenting healthy scalp. 7.Accepting not to use products with same end benefit, during the study. 8.Cooperating, informed of the need and duration of the examinations. 9.For which the investigator considers that the compliance will be correct.
Exclusion criteria
Exclusion criteria: 1. Cutaneous illness, localized on tested areas, which could interfere with the clinical evaluation. 2. History of allergic dermatitis to cosmetics or hair care products. 3. Subjects taking treatment for hair fall ? local - during last 1month ? or using minoxidil during last 3 months ? and systemic - during last 3 months 4. Subjects on any other local (during last 1month) or systemic (during last 3 months) medical treatment that could interfere with hair growth or hair loss e.g. vasodilators, steroids etc. 5. Haemoglobin less than 10 g/dl by blood test 6. Subjects with history of medical/surgical events that may significantly affect the study outcome e.g. h/o typhoid or jaundice etc. 7. Hyper sensitivity to any component of the tested product, 8. Volunteers exposed to intense sunlight. 9. Any acute or chronic disease. 10. Subject in an exclusion period or participating in another similar cosmetic or therapeutic trial as identified during screening on visit 1 (V1).
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Clinical Evaluation for Tolerance of the test product on scalp.Timepoint: Day 87, Day 177 | — |
Primary
| Measure | Time frame |
|---|---|
| The Primary Evaluation criteria (Primary Objective) for this study: - Evaluation of Anagen-Telogen ratio using Phototrichogram (TrichoScan). Timepoint: Day 4, Visit 90, Visit 180;The Primary Evaluation criteria (Primary Objective) for this study: - Evaluation of Anagen-Telogen ratio using Phototrichogram (TrichoScan). Timepoint: Day 4, Visit 90, Visit 180;The Primary Evaluation criteria (Primary Objective) for this study: - Evaluation of Anagen-Telogen ratio using Phototrichogram (TrichoScan). Timepoint: Day 4, Visit 90, Visit 180 | — |
Countries
India
Contacts
Public ContactDr Anil Shukla
Outcome results
None listed